Verified peer comparison
SuperCom vs Inhibikase Therapeutics Financial Comparison
Direct answer
SuperCom and Inhibikase Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free SuperCom email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- SuperCom Revenue
- 27,896,000 USD
- Inhibikase Therapeutics Revenue
- 0 USD
- SuperCom Operating income
- -322,000 USD
- Inhibikase Therapeutics Operating income
- -51,974,283 USD